May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Transfection of Short Interfering RNA to Supress ICAM–1 in Human Retinal Endothelial Cells
Author Affiliations & Notes
  • A. Kato
    Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
  • N. Kuno
    Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
  • A. Nishiwaki
    Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
  • E. Sakurai
    Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
  • Y. Ogura
    Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
  • Footnotes
    Commercial Relationships  A. Kato, None; N. Kuno, None; A. Nishiwaki, None; E. Sakurai, None; Y. Ogura, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4183. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Kato, N. Kuno, A. Nishiwaki, E. Sakurai, Y. Ogura; Transfection of Short Interfering RNA to Supress ICAM–1 in Human Retinal Endothelial Cells . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4183.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Short interfering RNAs (siRNAs) are powerful sequence specific reagents that suppress gene expression in mammalian cells. The purpose of this study is to demonstrate that transfection of siRNAs into human retinal endotherial cells (HRECs) specifically reduced endogeneous expression of ICAM–1 upon cytokine stimulation. Methods:HRECs were cultured and seeded in the plates, the next day transfection was performed with ICAM–1 specific siRNA and Lipofectamine 2000. IL–1ß was added to the medium for stimulation of ICAM–1. After 24 hours, HRECs were collected and determined ICAM–1–specific target protein by ELISA. Total RNA was extracted from another HRECs and ICAM–1 specific target RNA was determined by quantitative RT–PCR. Fluorescein–conjugate control siRNA combined with lipofectamine 2000 was transfected in HRECs, after 24 hours, HRECs were observed by fluorescein microscopy. Results: Protein expression of ICAM–1 was significantly reduced in transfected ICAM–1 siRNA cells compared with control cells. Messenger–RNA expression was also reduced up to 50% by ICAM–1 siRNA. Fluorescein–conjugate control siRNA was transfected into the HRECs especially into the nucleus. Conclusions: Short interfering RNA suppressed gene expression of ICAM–1 in HRECs, this finding suggests that RNA–targeting approach may provide a novel therapeutic option for reinal neovascularization and ischemic retinal disorders.

Keywords: vascular cells • cell adhesions/cell junctions • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×